Skip to content
Markets News
Stocks1 min read

Medpace Gains as Major U.S. Indexes Close Lower

Makkler Newsroom
September 29, 2026

Shares rose 1% as the S&P 500, Dow and Nasdaq declined; analysts expect earnings growth in Medpace’s October report.

Medpace shares closed 1% higher at $622.11 in the latest session, while the S&P 500 fell 0.17%. The Dow lost 0.26%, and the Nasdaq declined 0.09%.

Over the past month, the stock gained 3.7%. The Medical sector fell 0.67% and the S&P 500 lost 0.24% over the same period.

Medpace is scheduled to report earnings on October 21, 2026. Analysts expect quarterly earnings of $4.45 per share, up 15.28% from a year earlier, and revenue of $708.75 million, a 7.4% increase.

For the annual period, Zacks consensus estimates call for earnings of $17.54 per share and revenue of $2.84 billion. Those forecasts represent year-over-year growth of 14.79% and 12.38%, respectively; the consensus earnings estimate was unchanged over the past 30 days.

Zacks put Medpace’s forward P/E ratio at 35.12, compared with an industry average of 16.95. The ratio compares a company’s share price with its expected earnings.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.